Stock Events

Biomarin Pharmaceutical (BMRN) Q2 2017 Earnings

4MayConfirmed
Q3 2016
Q4 2016
Q1 2017
Q2 2017
-0.53
0.01
0.54
1.08

Details

Expected EPS
-0.29
Actual EPS
-0.09
Surprise EPS
0.2
Surprise Percent
+68.97%

Description

Biomarin Pharmaceutical (BMRN) has reported earnings of -0.09 per share for Q2 2017.

0 Comments

Share your thoughts